- Filed
- Feb 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 14, 2025 | 948.17M sh |
| Short Term Investments | FY 2024 · Dec 31, 2024 | $154.8M |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $109.1M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $18.32B |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.82B |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $10.77B |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $27.29B |
| Current Assets | FY 2024 · Dec 31, 2023 | $25.73B |
| Total Assets | FY 2024 · Dec 31, 2023 | $64.01B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 904.62M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $1.5B |
| Dividends Paid | FY 2024 · Dec 31, 2022 | $3.54B |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | $7.59B |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $6.90 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $6.93 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $6.44B |
| Net Income | FY 2024 · Dec 31, 2022 | $6.24B |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $6.63B |
| Revenue | FY 2024 · Dec 31, 2022 | $28.54B |